BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26916326)

  • 1. [Lacosamide and neuropathic pain, a review].
    Alcántara-Montero A; Sánchez-Carnerero CI
    Rev Neurol; 2016 Mar; 62(5):223-9. PubMed ID: 26916326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience.
    Alcántara Montero A; Sánchez Carnerero CI
    Neurologia (Engl Ed); 2019; 34(6):386-395. PubMed ID: 28215909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lacosamide as an alternative in the treatment of post-surgery neuropathic pain in an allergic patient].
    Monge-Márquez ME; Márquez-Rivas J; Mayorga-Buiza MJ; Rivero-Garvía M
    Rev Neurol; 2013 Oct; 57(7):313-6. PubMed ID: 24052442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug treatment for neuropathic pain].
    Attal N
    Presse Med; 2008 Feb; 37(2 Pt 2):346-53. PubMed ID: 18178057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of neuropathic pain with lacosamide].
    García-Escrivá A; López-Hernández N; Gil-Cortés C
    Rev Neurol; 2012 Feb; 54(3):167-72. PubMed ID: 22278893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
    Dworkin RH; O'Connor AB; Audette J; Baron R; Gourlay GK; Haanpää ML; Kent JL; Krane EJ; Lebel AA; Levy RM; Mackey SC; Mayer J; Miaskowski C; Raja SN; Rice AS; Schmader KE; Stacey B; Stanos S; Treede RD; Turk DC; Walco GA; Wells CD
    Mayo Clin Proc; 2010 Mar; 85(3 Suppl):S3-14. PubMed ID: 20194146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of neuropathic pain].
    Yeng LT
    Drugs Today (Barc); 2009 Oct; 45 Suppl C():7-12. PubMed ID: 20087480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of lacosamide in the treatment of refractory neuropathic pain: an open observational trial].
    Gómez-Argüelles JM; Bermejo PE; Lara M; Almajano J; Aragón E; García del Carrizo F; Blanco MV; Valenzuela-Rojas FJ; Colás J; Sánchez-Del Valle O; Ceballos MÁ; Toribio-Díaz ME; Latorre-González G; Costa-Frossard L; Morin-Martin Mdel M
    Rev Neurol; 2014 Oct; 59(7):289-93. PubMed ID: 25245872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide for the treatment of diabetic neuropathic pain.
    Biton V
    Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFNS guidelines on pharmacological treatment of neuropathic pain.
    Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
    Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update in the pharmacological treatment of neuropathic pain].
    Alcántara Montero A; Ibor Vidal PJ; Alonso Verdugo A; Trillo Calvo E
    Semergen; 2019; 45(8):535-545. PubMed ID: 31337589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of neuropathic pain.
    Jensen TS; Finnerup NB
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):126-31. PubMed ID: 18685353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
    Alcantara-Montero A
    Rev Neurol; 2017 Mar; 64(5):219-226. PubMed ID: 28229443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
    Beyreuther B; Callizot N; Stöhr T
    Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anticonvulsants for possible use in neuropathic pain.
    Waszkielewicz AM; Gunia A; Słoczyńska K; Marona H
    Curr Med Chem; 2011; 18(28):4344-58. PubMed ID: 21861814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsants (antineuropathics) for neuropathic pain syndromes.
    Backonja MM
    Clin J Pain; 2000 Jun; 16(2 Suppl):S67-72. PubMed ID: 10870743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic pain in cancer.
    Fallon MT
    Br J Anaesth; 2013 Jul; 111(1):105-11. PubMed ID: 23794652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.